Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
Open Access
- 6 June 2013
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 6,p. CD008933
- https://doi.org/10.1002/14651858.cd008933.pub2
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple SclerosisArchives of Neurology, 2010
- Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trialThe Lancet Neurology, 2010
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trialThe Lancet Neurology, 2008
- Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyThe Lancet Neurology, 2006
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Bayesian Measures of Model Complexity and FitJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983